More
    Guided Solutions - Connecting Talent With Innovation/div>

    GS MedTech Funding Tracker – Kestra, Akura and more

    This week’s MedTech lineup spans major financings and meaningful progress across multiple therapeutic areas. Companies developing advanced thrombectomy systems, vascular-access implants, heart-failure therapies, and AI-powered cancer diagnostics all secured new backing, alongside novel approaches...

    GS MedTech Funding Tracker – Kestra, Akura and more

    This week’s MedTech lineup spans major financings and meaningful progress across multiple therapeutic areas. Companies developing advanced thrombectomy systems, vascular-access implants, heart-failure therapies, and...

    Atraverse wins FDA clearance for left heart access device

    Atraverse Medical announced that it received FDA clearance for its fully integrated Hotwire transseptal access system. Hotwire is a novel radiofrequency guidewire left-heart access device....

    Kestra Medical Technologies prices $138M offering

    Kestra Medical Technologies announced that it priced an upsized underwritten offering worth approximately $138 million. The Kirkland, Washington-based company said its offering includes 6 million...

    FDA clears Francis Medical’s water vapour ablation treatment for prostate cancer

    Francis Medical’s Vanquish device for treating intermediate-risk prostate cancer has been cleared by the US Food and Drug Administration (FDA). Vanquish is a transurethral, ultrasound...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    JenaValve reports positive Trilogy heart valve data for aortic regurgitation

    JenaValve announced new results from an expanded patient cohort supporting the use of its Trilogy transcatheter heart valve (THV) system. Results from the ALIGN-AR pivotal...

    Vexev robotic ultrasound study meets endpoints

    Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...

    Hyperion completes first-in-human study of Ivy robotic vascular access platform

    Hyperion Surgical announced today that it completed the world’s first robotic-assisted intravenous (IV) catheterisation using its Ivy platform. Ivy integrates advanced imaging, AI and robotic...

    AtriCure treats first patient in the BoxX-NoAF clinical trial

    AtriCure, a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced...

    Innovation

    Regulatory Approvals

    GS MedTech Funding Tracker – Kestra, Akura and more

    This week’s MedTech lineup spans major financings and meaningful progress across multiple therapeutic areas. Companies developing advanced thrombectomy systems, vascular-access implants, heart-failure therapies, and...

    Atraverse wins FDA clearance for left heart access device

    Atraverse Medical announced that it received FDA clearance for its fully integrated Hotwire transseptal access system. Hotwire is a novel radiofrequency guidewire left-heart access device....

    Kestra Medical Technologies prices $138M offering

    Kestra Medical Technologies announced that it priced an upsized underwritten offering worth approximately $138 million. The Kirkland, Washington-based company said its offering includes 6 million...

    FDA clears Francis Medical’s water vapour ablation treatment for prostate cancer

    Francis Medical’s Vanquish device for treating intermediate-risk prostate cancer has been cleared by the US Food and Drug Administration (FDA). Vanquish is a transurethral, ultrasound...

    M&A

    Archives

    Latest articles